{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:20:29Z","timestamp":1791404429500,"version":"4.3.3"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"Purpose:<\/jats:bold> Chemotherapy-induced gastrointestinal (CIGI) toxicity affects the quality of life of patients with colorectal cancer (CRC) and the clinical application of treatment drugs. This review aims to evaluate the efficacy of traditional herbal medicines (HMs) in alleviating symptoms of CIGI toxicity (including nausea and vomiting, anorexia, diarrhea, constipation, oral mucositis, abdominal pain, and abdominal distension), and to explore further individual herb or herbal combinations in alleviating the CIGI toxicity.<\/jats:p>Methods:<\/jats:bold> Nine electronic databases were screened from 2010 to 2020. Twenty-two randomized controlled trials with a total of 1,995 patients evaluating the complementary efficacy of HMs with chemotherapy compared with chemotherapy-alone were included. Further, sensitivity analyses of orally administered multi-ingredient HM interventions were explored based on the composition of HM interventions.<\/jats:p>Results:<\/jats:bold> The meta-analysis showed that HM treatment combined with chemotherapy significantly alleviated the overall CIGI toxicity (RR = 0.78 [0.72, 0.84], p<\/jats:italic> &lt; 0.001, I<\/jats:italic>2<\/jats:sup> = 44%), nausea and vomiting (RR = 0.74 [0.66, 0.82], p<\/jats:italic> &lt; 0.001, I<\/jats:italic>2<\/jats:sup> = 35%), diarrhea (P<\/jats:italic> = 0.02, RR = 0.64, 95% CI = 0.44\u20130.93, I<\/jats:italic>2<\/jats:sup> = 50%), oral mucositis (RR = 0.65 [0.48, 0.88], P<\/jats:italic> = 0.005, I<\/jats:italic>2<\/jats:sup> = 24%), and abdominal distension (RR = 0.36 [0.18, 0.73], P<\/jats:italic> = 0.004, I<\/jats:italic>2<\/jats:sup> = 0%). However, no statistically significant effects of HMs were shown in studies with a double-blind design for CIGI toxicity. Based on the ingredients of the HMs, further sensitivity analyses identified five herbs [Glycyrrhiza uralensis<\/jats:italic> Fisch., Atractylodes macrocephala<\/jats:italic> Koidz., Astragalus membranaceus<\/jats:italic> (Fisch.) Bge., Codonopsis pilosula<\/jats:italic> (Franch.) Nannf., and the pericarp of Citrus reticulata<\/jats:italic> Blanco.] that were associated with significant reductions in CIGI toxicity.<\/jats:p>Conclusion:<\/jats:bold> A statistically significant effect of HMs combined with chemotherapy on alleviating the overall CIGI toxicity, nausea and vomiting, diarrhea, oral mucositis, or abdominal distension is only shown in studies without a double-blind design. Further well-designed, double-blinded, large-scaled randomized controlled trials (RCTs) are warranted to comprehensively evaluate the treatment efficacy. Further clinical research that includes the five herbs with chemotherapy for patients, the safety of the combinations of these herbs, and the potential synergistic effects of these combinations of herbs should be conducted.<\/jats:p>","DOI":"10.3389\/fonc.2021.629132","type":"journal-article","created":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T05:53:52Z","timestamp":1616651632000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Efficacy of Herbal Medicines Intervention for Colorectal Cancer Patients With Chemotherapy-Induced Gastrointestinal Toxicity \u2014 a Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"11","author":[{"given":"Yuanyuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-shan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hor-Yue","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Wing","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/14737140.2019.1543593","article-title":"The changing face of treatment for metastatic colorectal cancer","volume":"19","author":"Pfeiffer","year":"2019","journal-title":"Expert Rev Anticancer Ther"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1093\/annonc\/mds236","article-title":"ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making","volume":"23","author":"Schmoll","year":"2012","journal-title":"Ann Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.2217\/fon.15.138","article-title":"What are the predictive factors in the risk and severity of chemotherapy-induced gastrointestinal toxicity?","volume":"11","author":"Gibson","year":"2015","journal-title":"Future Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"Cd006875","DOI":"10.1002\/14651858.CD006875.pub3","article-title":"Second-line systemic therapy for metastatic colorectal cancer","volume":"1","author":"Mocellin","year":"2017","journal-title":"Cochrane Datab Syst Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/cncr.28592","article-title":"MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy","volume":"120","author":"Lalla","year":"2014","journal-title":"Cancer."},{"key":"B7","first-page":"106","article-title":"Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management","volume":"25","author":"Boussios","year":"2012","journal-title":"Ann Gastroenterol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s00520-020-05610-x","article-title":"The FOCCUS study: a prospective evaluation of the frequency, severity and treatable causes of gastrointestinal symptoms during and after chemotherapy","volume":"29","author":"Andreyev","year":"2020","journal-title":"Support Care Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"48385","DOI":"10.18632\/oncotarget.16801","article-title":"The effects of herbal medicine on epilepsy","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"B10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3969\/j.issn.1672-2779.2017.04.023","article-title":"Meta-analysis on effect and safety of Chinese medicine combined with chemotherapy in the treatment of advenced colorectal cancer","volume":"4","author":"Wang","year":"2017","journal-title":"Chin Med Modern Dist Educ China"},{"key":"B11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ctim.2012.02.004","article-title":"The efficacy of Chinese herbal medicine as an adjunctive therapy for colorectal cancer: a systematic review and meta-analysis","volume":"20","author":"Zhong","year":"2012","journal-title":"Complement Therap Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1177\/1534735416638738","article-title":"Chinese herbal medicine and fluorouracil-based chemotherapy for colorectal cancer: a quality-adjusted meta-analysis of randomized controlled trials","volume":"15","author":"McCulloch","year":"2016","journal-title":"Integ Cancer Therap."},{"key":"B13","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3389\/fonc.2019.00749","article-title":"Meta-analysis of astragalus-containing traditional chinese medicine combined with chemotherapy for colorectal cancer: efficacy and safety to tumor response","volume":"9","author":"Lin","year":"2019","journal-title":"Front Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"B15","year":"2006","journal-title":"Common Terminology Criteria for Adverse Events (CTCAE) v3.0"},{"key":"B16","volume-title":"Guidelines for Clinical Research of New Chinese Medicines","author":"Zheng","year":"2002"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials."},{"key":"B18","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet."},{"key":"B19","unstructured":"HigginsJ\n ThomasJ\n ChandlerJ\n CumpstonM\n LiT\n PageM\n Cochrane Handbook for Systematic Reviews of Interventions Version 6.12020"},{"key":"B20","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/ptr.5586","article-title":"Integrative medicine for relief of nausea and vomiting in the treatment of colorectal cancer using oxaliplatin-based chemotherapy: a systematic review and meta-analysis","volume":"30","author":"Chen","year":"2016","journal-title":"Phytother Res"},{"key":"B21","first-page":"2233","article-title":"A clinical study on safety and efficacy of Aidi injection combined with chemotherapy","volume":"12","author":"Xu","year":"2011","journal-title":"Asian Pac J Cancer Prev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.3969\/j.issn.1008-8849.2016.21.031","article-title":"FOLFOX4 chemotherapy combined with self-made traditional Chinese medicine Fuzheng Xiaoji Decoction in the treatment of advanced colon cancer","volume":"21","author":"Ji","year":"2016","journal-title":"Mod J Integrat Tradit Chin Western Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3969\/j.issn.1008-8849.2019.06.018","article-title":"Clinical effect and safety of FOLFOX4 chemotherapy combined with Chinese medicine Fuzheng Xiaoji Decoction in the treatment of patients with advanced colon cancer","volume":"28","author":"Li","year":"2019","journal-title":"Mod J Integrat Tradit Chin Western Med."},{"key":"B24","first-page":"444","article-title":"Clinical observation of Shenlingbaizhu powder combined with IFL regimen in treatment of advanced colorectal cancer patients with chemotherapy","volume":"19","author":"Hu","year":"2015","journal-title":"Pub Med Forum Magazine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3760\/cma.j.issn.1673-4246.2016.06.011","article-title":"A clinical study of XELOX chemotherapy combined with Chinese herbal medicines for obstructive colorectal cancer","volume":"38","author":"Xing","year":"2016","journal-title":"Int J Trad Chin Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"6189","DOI":"10.3969\/j.issn.1005-9202.2016.24.068","article-title":"Effect of Chinese medicine on gastrointestinal function of patients with colorectal cancer after chemotherapy","volume":"24","author":"Huang","year":"2016","journal-title":"Chin Gastroenterol J"},{"key":"B27","first-page":"1161","article-title":"Effects of qisheng mixture on chemotherapy induced myelosuppression in patients with colorectal cancer","volume":"32","author":"Chen","year":"2012","journal-title":"Chin J Integrated Tradit Western Med."},{"key":"B28","first-page":"164","article-title":"Immune enhancing effect of modified sijunzi decoction on patients with colorectal cancer undergoing chemotherapy","volume":"31","author":"Xiao","year":"2011","journal-title":"Chin J Integrated Tradit Western Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"871","DOI":"10.7501\/j.issn.0253-2670.2015.06.016","article-title":"Effect of Xihuang Capsules in adjuvant treatment of colon cancer patients with liver metastases and on IL-17 and IL-6 in serum of patients","volume":"46","author":"Zhang","year":"2015","journal-title":"Chin Tradit Herbal Drugs."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.6039\/j.issn.1001-0408.2016.33.13","article-title":"Clinical observation of shenling baishu powder addition and subtraction combined with chemotherapy in the treatment of advanced colorectal cancer","author":"Nan","year":"2016","journal-title":"China Pharmacy"},{"key":"B31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.14163\/j.cnki.11-5547\/r.2019.31.063","article-title":"A clinical study of traditional Chinese medicine Pobi decoction on improving adverse reactions of patients with colorectal cancer chemotherapy","volume":"31","author":"Song","year":"2019","journal-title":"China Pract Med."},{"key":"B32","article-title":"Clinical effect observation of chemotherapy combined with Chinese herbs treatment after colorectal cancer surgery","author":"Zhang","year":"2015","journal-title":"China Modern Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.15887\/j.cnki.13-1389\/r.2016.05.005","article-title":"The clinical adverse reactions of cooperation of Chinese and western medicine treatment for advanced colorectal cancer","volume":"5","author":"Peng","year":"2016","journal-title":"Chin J Clin Rational Drug Use"},{"key":"B34","first-page":"52","article-title":"An effect of chemotherapy plus TCM medicine on colorectal cancer after operation","volume":"2","author":"Zeng","year":"2018","journal-title":"Clin J Chin Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s10147-020-01648-3","article-title":"Prophylactic efficacy of ninjin'yoeito for oxaliplatin-induced cumulative peripheral neuropathy in patients with colorectal cancer receiving postoperative adjuvant chemotherapy: a randomized, open-label, phase 2 trial (HOPE-2)","volume":"25","author":"Motoo","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00280-013-2306-7","article-title":"Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy","volume":"72","author":"Kono","year":"2013","journal-title":"Cancer Chemother Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"541217","DOI":"10.1155\/2013\/541217","article-title":"Clinical study on the prevention of oxaliplatin-induced neurotoxicity with guilongtongluofang: results of a randomized, double-blind, placebo-controlled trial","volume":"2013","author":"Liu","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10147-015-0784-9","article-title":"Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study","volume":"20","author":"Oki","year":"2015","journal-title":"Int J Clin Oncol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00280-015-2767-y","article-title":"Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis","volume":"76","author":"Matsuda","year":"2015","journal-title":"Cancer Chemother Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3969\/j.issn.1674-7860.2014.30.057","article-title":"Research on curative effect of combined traditional Chinese medicine and western medicine on advanced colon cancer","volume":"6","author":"Liu","year":"2014","journal-title":"Clin J Chin Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3969\/j.issn.1671-3141.2015.39.026","article-title":"Observation on the clinical efficacy of combination of Chinese and western medicines in treating colon cancer","volume":"15","author":"Zhao","year":"2015","journal-title":"World Latest Med Informat."},{"key":"B42","first-page":"379","article-title":"Clinical effect of TCM of tonifying spleen and removing blood stasis in gastrointestinal function of postoperative patients with chemotherapy of colorectal cancer","volume":"18","author":"Hu","year":"2016","journal-title":"Chin J Med Guide"},{"key":"B43","year":"1999","journal-title":"Common Toxicity Criteria (CTC) v2.0"},{"key":"B44","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s00134-011-2459-y","article-title":"Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working group on abdominal problems","volume":"38","author":"Reintam Blaser","year":"2012","journal-title":"Intensive Care Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e2793","DOI":"10.1097\/MD.0000000000002793","article-title":"Chinese herbal medicine for symptom management in cancer palliative care: systematic review and meta-analysis","volume":"95","author":"Chung","year":"2016","journal-title":"Medicine."},{"key":"B46","first-page":"5788","article-title":"The efficacy of compound kushen injection in preventing and treating radiation-induced oral mucositis: a systematic review and meta-analysis","volume":"10","author":"Yuan","year":"2017","journal-title":"Int J Clin Exp Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/ije\/dyu115","article-title":"Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies","volume":"43","author":"Hr\u00f3bjartsson","year":"2014","journal-title":"Int J Epidemiol"},{"key":"B48","first-page":"1495","article-title":"Radix Codonopsi polysaccharide against 5-fluorouracil-induced gastrointestinal mucositis in mice model","volume":"43","author":"Zhou","year":"2016","journal-title":"Liaon J Tradit Chin Med."},{"key":"B49","first-page":"444","article-title":"Effects of extracts from codonopsis pilosula and atractylodes macrocephala on growth and differentiation of IEC-6 cells","volume":"18","author":"Chen","year":"2002","journal-title":"Chin Pharmacol Bull."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.11958\/20170739","article-title":"Effects of extracts of pericarpium citri reticulatae and pogostemon cablin on the contraction of gastrointestinal smooth muscle and gastrointestinal hormones in rats with gastrointestinal motility disorder","volume":"45","author":"He","year":"2017","journal-title":"Tianjin Med J."},{"key":"B51","doi-asserted-by":"publisher","first-page":"367","DOI":"10.12047\/j.cjap.5616.2018.084","article-title":"Effect of Angelica sinensis radix on colonic morphology and mucus secretion of experimental XuexuBianmi model mice","volume":"34","author":"Du","year":"2018","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"key":"B52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1079\/BJN20041295","article-title":"Effects of Si-Jun-Zi decoction polysaccharides on cell migration and gene expression in wounded rat intestinal epithelial cells","volume":"93","author":"Liu","year":"2005","journal-title":"Br J Nutr."},{"key":"B53","first-page":"532","article-title":"Clinical study on Jiawei Sijunzi Decoction on synergism and attenuation of chemotherapy for patients with spleen and stomach qi deficiency syndrome after rectal cancer operation","volume":"39","author":"Ni","year":"2019","journal-title":"J Hunan University Chin Med."},{"key":"B54","first-page":"204","article-title":"Meta-analysis of chemotherapy combined with Sijunzi Tang in treatment of patients with colorectal cancer","volume":"22","author":"Li","year":"2016","journal-title":"Chin J Experi Tradit Med Formul."},{"key":"B55","first-page":"7","article-title":"Action of traditional Chinese medicine of buqi on contractile activity of isolated gastric muscle strops in rats","volume":"24","author":"Zheng","year":"1998","journal-title":"J Lanzhou Med Coll"},{"key":"B56","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3390\/ph13120455","article-title":"Exploring herbal medicine use during palliative cancer care: the integrative physician as a facilitator of pharmacist-patient-oncologist communication","volume":"13","author":"Samuels","year":"2020","journal-title":"Pharmaceuticals."},{"key":"B57","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jpha.2019.01.005","article-title":"Analysis of pesticide residues in commercially available chenpi using a modified QuEChERS method and GC-MS\/MS determination","volume":"10","author":"Li","year":"2020","journal-title":"J Pharm Anal."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e042686","DOI":"10.1136\/bmjopen-2020-042686","article-title":"Efficacy, safety and response predictors of adjuvant astragalus for diabetic kidney disease (READY): study protocol of an add-on, assessor-blind, parallel, pragmatic randomised controlled trial","volume":"11","author":"Chan","year":"2021","journal-title":"BMJ Open."},{"key":"B59","doi-asserted-by":"publisher","first-page":"111921","DOI":"10.1016\/j.jep.2019.111921","article-title":"Astragalus membranaceus (Huang Qi) as adjunctive therapy for diabetic kidney disease: an updated systematic review and meta-analysis","volume":"239","author":"Zhang","year":"2019","journal-title":"J Ethnopharmacol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"347525","DOI":"10.1155\/2013\/347525","article-title":"Open randomized clinical trial on JWSJZ decoction for the treatment of ALS patients","volume":"2013","author":"Pan","year":"2013","journal-title":"Evid Based Complement Alternat Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1560353","DOI":"10.1155\/2020\/1560353","article-title":"Clinical and preclinical systematic review of astragalus membranaceus for viral myocarditis","volume":"2020","author":"Zheng","year":"2020","journal-title":"Oxid Med Cell Longev."},{"key":"B62","article-title":"Subacute toxicity study on Sagunjia-tang(Sijunzi-tang) in SD rats","author":"Ma","year":"2007","journal-title":"Korean J Oriental Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3389\/fonc.2019.01356","article-title":"Herbal Interaction with chemotherapeutic drugs-a focus on clinically significant findings","volume":"9","author":"Fasinu","year":"2019","journal-title":"Front Oncol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.2105\/AJPH.2007.124537","article-title":"Adverse event detection in drug development: recommendations and obligations beyond phase 3","volume":"98","author":"Berlin","year":"2008","journal-title":"Am J Public Health"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.629132\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T06:02:22Z","timestamp":1616652142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.629132\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,25]]},"references-count":64,"alternative-id":["10.3389\/fonc.2021.629132"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.629132","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,25]]},"article-number":"629132"}}